statistiche ricercatore

DENTALI, FRANCESCO

Distribuzione geografica

Continente	#
NA - Nord America	32.608
EU - Europa	15.816
AS - Asia	11.859
SA - Sud America	1.447
AF - Africa	228
Continente sconosciuto - Info sul continente non disponibili	37
OC - Oceania	16
Totale	62.011

Salva come PNG Salva come JPEG

Nazione	#
US - Stati Uniti d'America	32.249
IT - Italia	7.210
SG - Singapore	3.965
CN - Cina	2.425
UA - Ucraina	2.303
TR - Turchia	1.662
VN - Vietnam	1.589
HK - Hong Kong	1.437
SE - Svezia	1.226
DE - Germania	1.215
BR - Brasile	1.185
IE - Irlanda	808
FI - Finlandia	724
GB - Regno Unito	690
FR - Francia	663
RU - Federazione Russa	502
IN - India	226
CA - Canada	171
MX - Messico	152
JP - Giappone	96
BD - Bangladesh	93
AR - Argentina	91
NL - Olanda	91
PL - Polonia	73
ES - Italia	67
IQ - Iraq	66
ZA - Sudafrica	66
AT - Austria	62
NG - Nigeria	42
PK - Pakistan	41
LT - Lituania	36
BE - Belgio	34
EC - Ecuador	33
EU - Europa	29
MA - Marocco	28
SA - Arabia Saudita	28
CL - Cile	27
CO - Colombia	27
VE - Venezuela	27
UZ - Uzbekistan	26
ID - Indonesia	25
KE - Kenya	21
CZ - Repubblica Ceca	20
IL - Israele	20
PY - Paraguay	18
AE - Emirati Arabi Uniti	17
JO - Giordania	17
MY - Malesia	16
PH - Filippine	16
AU - Australia	15
EG - Egitto	15
BO - Bolivia	13
RO - Romania	13
TN - Tunisia	13
UY - Uruguay	13
CH - Svizzera	12
PE - Perù	12
GR - Grecia	11
PT - Portogallo	11
AZ - Azerbaigian	10
IR - Iran	10
NP - Nepal	9
AL - Albania	8
DZ - Algeria	8
KR - Corea	8
SN - Senegal	8
TH - Thailandia	8
CI - Costa d'Avorio	7
ET - Etiopia	7
LB - Libano	7
TW - Taiwan	7
HN - Honduras	6
HU - Ungheria	6
OM - Oman	6
RS - Serbia	6
DO - Repubblica Dominicana	5
KZ - Kazakistan	5
TT - Trinidad e Tobago	5
AO - Angola	4
GT - Guatemala	4
JM - Giamaica	4
KW - Kuwait	4
MK - Macedonia	4
NO - Norvegia	4
XK - ???statistics.table.value.countryCode.XK???	4
A2 - ???statistics.table.value.countryCode.A2???	3
AM - Armenia	3
BA - Bosnia-Erzegovina	3
CR - Costa Rica	3
DK - Danimarca	3
GE - Georgia	3
BH - Bahrain	2
BY - Bielorussia	2
DM - Dominica	2
LI - Liechtenstein	2
LK - Sri Lanka	2
MD - Moldavia	2
NI - Nicaragua	2
PA - Panama	2
PS - Palestinian Territory	2
Totale	61.983

Salva come PNG Salva come JPEG

Città	#
Milan	5.050
Fairfield	4.108
Ashburn	2.734
Woodbridge	2.671
San Jose	2.308
Singapore	2.196
Houston	1.951
Jacksonville	1.808
Seattle	1.610
Wilmington	1.505
Hong Kong	1.420
Chandler	1.387
Cambridge	1.385
Ann Arbor	1.312
Dallas	870
Izmir	816
Dublin	802
Princeton	787
The Dalles	674
Dearborn	591
Nyköping	539
Beijing	512
Boardman	504
Lauterbourg	421
Dong Ket	367
Chicago	352
Rome	333
Ho Chi Minh City	309
Munich	300
Los Angeles	264
San Diego	245
New York	226
Helsinki	203
London	196
Hanoi	194
San Mateo	159
Ogden	152
Santa Clara	148
São Paulo	135
Como	127
Council Bluffs	120
Orem	114
Guangzhou	107
Washington	105
Mexico City	97
Tokyo	82
Nuremberg	79
Frankfurt am Main	74
Düsseldorf	71
Chennai	68
Montreal	67
Hefei	64
Shanghai	63
Redmond	62
Nanjing	60
Buffalo	57
Warsaw	56
Turku	55
Kunming	54
Verona	54
Norwalk	53
Brooklyn	52
Salt Lake City	51
Tianjin	49
Hangzhou	48
Manchester	48
Denver	47
Phoenix	47
Haiphong	44
Paris	44
Shenzhen	43
Atlanta	42
Toronto	42
Stockholm	41
Abuja	39
Amsterdam	39
Johannesburg	39
Kocaeli	39
Rio de Janeiro	38
Boston	37
San Francisco	37
Varese	37
Belo Horizonte	34
Jinan	33
Elk Grove Village	32
Poplar	31
Da Nang	30
Kilburn	30
Brussels	29
Mumbai	29
Columbus	27
Tampa	27
Zhengzhou	27
Nanchang	24
Tashkent	24
Baghdad	22
Vienna	22
Ankara	21
Falkenstein	21
Besana In Brianza	20
Totale	44.619

Salva come PNG Salva come JPEG

Nome	#
Impact of neutrophils to lymphocytes ratio on major clinical outcomes in patients with acute coronary syndromes: A systematic review and meta-analysis of the literature	372
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both	351
Vitamin K antagonists in the era of direct oral anticoagulants: is there still a room for their use?	323
A survey of thrombosis prophylaxis use in patients undergoing arthroscopic surgery	307
A clinical score to rule out the concomitant presence of deep vein thrombosis in patients presenting with superficial vein thrombosis: The ICARO study	297
Prognostic significance of residual venous obstruction in patients with treated unprovoked deep vein thrombosis: a patient-level meta-analysis	293
Effect of Vitamin K Intake on the Stability of Treatment with Vitamin K Antagonists: A Systematic Review of the Literature	262
Relationship between regulatory T cells subsets and lipid profile in dyslipidemic patients: A longitudinal study during atorvastatin treatment	256
Clinical history and antithrombotic treatment of incidentally detected splanchnic vein thrombosis: a multicentre, international prospective registry	255
Risk of recurrence of unusual site venous thromboembolism	252
ABO blood group and vascular disease: an update	248
Optimal treatment duration of venous thrombosis	247
Angiotensin II type 1 and type 2 receptor expression in circulating monocytes of diabetic and hypercholesterolemic patients over 3-month rosuvastatin treatment	244
Risk factors for suboptimal efficacy of 3-factor prothrombin complex concentrates in emergency vka anticoagulation reversal	244
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature	242
incidence of thromboembolic complications in patients with mechanical heart valves with a subtherapeutic international normalized ratio.	235
PCSK9 inhibitors for treating dyslipidemia in patients at different cardiovascular risk: a systematic review and a meta-analysis	234
Warfarin interactions with antibiotics in the ambulatory care setting	232
Association between ABCG2 and ABCB1 genes and warfarin stability: a case-control study	232
Pulmonary Embolism Severity Index Accurately Predicts Long-Term Mortality Rate In Patients Hospitalized For Acute Pulmonary Embolism	231
Unsuspected pulmonary embolism in cancer patients: a narrative review with pooled data	228
Incidence rates and case fatality rates of portal vein thrombosis and Budd-Chiari Syndrome	228
Venous ischemic syndromes	228
A multicentre randomised assessment of the DAWN AC computer-assisted oral anticoagulant dosage program.	227
Diagnostic accuracy of lung ultrasound for pulmonary embolism: a systematic review and meta-analysis.	225
Diagnosis and management of venous thromboembolism: Results of a survey on current clinical practice	225
Introduction of SARS-CoV-2 variant of concern 20h/501Y.V2 (B.1.351) from Malawi to Italy	223
Brain natriuretic peptide as a preclinical marker of chronic pulmonary hypertension in patients with pulmonary embolism.	220
A prospective validation of the Bova score in normotensive patients with acute pulmonary embolism	220
Prevalence and Clinical History of Incidental, Asymptomatic Pulmonary Embolism: A Meta-Analysis	217
Role of ABO blood group and of other risk factors on the presence of residual vein obstruction after deep-vein thrombosis	216
Presence of residual thromboemboli at least six months after a first episode of symptomatic pulmonary embolism: do perfusion scintigraphy and angio-computed tomography agree?	215
Inferior vena cava filter in patients with venous thromboembolism and major bleeding events: building the evidence	215
Patient selection for thromboprophylaxis in medical inpatients	214
Abdominal obesity and the risk of recurrent deep vein thrombosis.	211
Incidence of chronic pulmonary hypertension in patients with previous pulmonary embolism	211
Venous and arterial thrombosis in patients with HIV infection	209
Major Bleeding and Case Fatality Rate with the Direct Oral Anticoagulants in Orthopedic Surgery: A Systematic Review and Meta-Analysis	209
Prognostic stratification of chronic heart failure in elderly population: are cardiopulmonary tests and BNP really valuable?	207
Metabolic syndrome and hyperhomocysteinemia in patients with deep vein thrombosis: a case-control study	206
Atypical case of Acute Coronary Syndrome due to Coronary-Pulmonary Steal Syndrome secondary to Pulmonary Embolism.	205
Statin use and bleeding risk during vitamin K antagonist treatment for venous thromboembolism: A multicenter retrospective cohort study	205
Incidence of cancer after a first episode of idiopathic venous thromboembolism treated with 3 months or 1 year of oral anticoagulation	205
Non-vitamin K oral anticoagulants in patients with pulmonary embolism: a systematic review and meta-analysis of the literature	204
Predictors of residual venous obstruction after deep vein thrombosis of the lower limbs: a prospective cohort study	203
The role of inherited thrombophilia in patients with isolated pulmonary embolism: a systematic review and a meta-analysis of the literature	202
Time trends and case fatality rate of in-hospital treated pulmonary embolism during 11 years of observation in Northwestern Italy	202
Pulmonary embolism prognostic factors and length of hospital stay: A cohort study	201
Duration of anticoagulation after venous thromboembolism in real world clinical practice	200
Statins, fibrates, and venous thromboembolism: a meta-analysis.	199
Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens	199
Seasonal and monthly variation in occurrence of hypertensive urgency	198
Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians	196
sRAGE and early signs of cardiac target organ damage in mild hypertensives	196
Brain natriuretic peptide and preclinical chronic thromboembolic pulmonary hypertension.	195
Anticoagulant therapy for venous thromboembolism during pregnancy: a systematic review and a meta-analysis of the literature: a reply to a rebuttal	195
Prognostic role of neutrophils to lymphocytes ratio in patients with acute pulmonary embolism: a systematic review and meta-analysis of the literature	195
Statins and secondary prevention of ischemic and hemorrhagic stroke	194
Emergency reversal of anticoagulation with vitamin K antagonists with 3-factor prothrombin complex concentrates in patients with major bleeding	194
Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes	193
Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage	193
Gender Difference in Efficacy and Safety of Nonvitamin K Antagonist Oral Anticoagulants in Patients with Nonvalvular Atrial Fibrillation or Venous Thromboembolism: A Systematic Review and a Meta-Analysis of the Literature	193
Statins for acute ischemic stroke	193
Risk of Thromboembolism, Recurrent Hemorrhage, and Death after Warfarin Therapy Interruption for Gastrointestinal Tract Bleeding	193
Prevalence of renal failure and use of antithrombotic prophylaxis among medical inpatients at increased risk of venous thromboembolic events.	192
Diagnostic accuracy of magnetic resonance imaging in patients with suspected pulmonary embolism: A bivariate meta-analysis	192
Italian intersociety consensus on DOAC use in internal medicine	191
In vitro effects of Apixaban on 5 different cancer cell lines	191
Factors associated with anticoagulation prescription in elderly patients with atrial fibrillation	191
Risk of bleeding in low-risk atrial fibrillation patients on warfarin waiting for elective cardioversion.	190
Management of primary care patients with suspected deep vein thrombosis: use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation.	190
5 flourouracil-induced apical ballooning syndrome: a case report.	189
Cerebral venous thrombosis and myeloproliferative neoplasms: results from two large databases	189
Is diabetes a hypercoagulable state? A critical appraisal	189
Rapid salivary test suitable for a mass screening program to detect SARS-CoV-2: a diagnostic accuracy study	188
Abdominal pain as pulmonary embolism presentation, usefulness of bedside ultrasound: A report of two cases	187
JAK2V617F mutation for the early diagnosis of Ph- myeloproliferative neoplasms in patients with venous thromboembolism: a meta-analysis.	187
An unusual case of cerebral vein thrombosis in a patient with giant cell arteritis	186
The role of thrombolytic therapy in pulmonary embolism	186
Neutrophil-to-lymphocyte ratio: A new prognostic factor even in patients with heart failure	186
Prevention of in-hospital VTE: why can't we do better?	185
Mild antithrombin deficiency and risk of recurrent venous thromboembolism: a prospective cohort study	185
Recurrence of ICH after resumption of anticoagulation with VK antagonists: CHIRONE Study	185
Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events	184
A CLINICAL ASSESSMENT MODEL TO SELECT ELDERLY PATIENTS WITH CHRONIC ATRIAL FIBRILLATION FOR A SAFE WARFARIN TREATMENT	183
Low-molecular -weight heparin in pregnancies after ART -A retrospective study-	183
Antithrombotic and fibrinolytic drugs for retinal vein occlusion: a systematic review and a call for action.	183
Atypical case of acute coronary syndrome due to coronary-pulmonary steal syndrome secondary to pulmonary embolism.	182
Clinical utility of antithrombotic prophylaxis in ART procedures: an Italian experience	182
The effect of thyroid autoantibodies on warfarin stability	182
Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	182
Clinical Pregnancies and Live Births in women approaching ART: a follow-up analysis of 157 women after thrombophilia screening	181
External validation of the DASH prediction rule: a retrospective cohort study	181
General practitioner–performed compression ultrasonography for diagnosis of deep vein thrombosis of the leg: A multicenter, prospective cohort study	181
Antithrombin levels and the risk of a first episode of venous thromboembolism: a case-control study	180
Poor predictive value of contemporary bleeding risk scores during long-term treatment of venous thromboembolism: A multicentre retrospective cohort study	180
The prevention and treatment of venous thromboembolism in pregnancy	180
In-hospital mortality due to pulmonary embolism in patients with Alzheimer disease: A sex effect?	179
The initial phase of oral anticoagulation with warfarin in outpatients with deep venous thrombosis.	178
How I treat splanchnic vein thrombosis	178
Totale	21.122

Salva come PNG Salva come JPEG

Categoria	#
all - tutte	262.751
article - articoli	0
book - libri	0
conference - conferenze	0
curatela - curatele	0
other - altro	0
patent - brevetti	0
selected - selezionate	0
volume - volumi	0
Totale	262.751

Salva come PNG Salva come JPEG

	Totale	Lug	Ago	Sett	Ott	Nov	Dic	Gen	Feb	Mar	Apr	Mag	Giu
2020/2021	1.908	0	0	0	0	0	0	0	0	0	458	574	876
2021/2022	4.033	403	544	187	104	219	172	325	215	229	726	411	498
2022/2023	4.390	480	206	318	379	303	956	14	576	652	244	140	122
2023/2024	8.221	1.245	1.282	1.286	1.563	1.639	574	66	119	241	95	43	68
2024/2025	6.800	46	52	1.123	178	236	465	373	543	743	705	584	1.752
2025/2026	14.756	1.049	1.000	917	1.983	1.355	881	3.629	1.101	2.024	817	0	0
Totale													62.561